Circulating Serum Exosomal aHIF Is A Novel Prognostic Predictor For Epithelial Ovarian Cancer [Corrigendum]
Tang X, Liu S, Liu Y, et al. Onco Targets Ther.2019;12:7699–7711. Upon reviewing the article, the authors noticed an error in Figure 1A (page 7703). The authors had mixed up and uploaded the incorrect figure panel. The authors apologize for this error. The author...
Main Authors: | Tang X, Liu S, Liu Y, Lin X, Zheng T, Liu X, Qiu J, Hua K |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-11-01
|
Series: | OncoTargets and Therapy |
Online Access: | https://www.dovepress.com/httpswwwdovepresscomcorrigendum-circulating-serum-exosomal-ahif-is-a-n-peer-reviewed-article-OTT |
Similar Items
-
Circulating serum exosomal aHIF is a novel prognostic predictor for epithelial ovarian cancer
by: Tang X, et al.
Published: (2019-09-01) -
Circulating Haptoglobin Is an Independent Prognostic Factor in the Sera of Patients with Epithelial Ovarian Cancer
by: Changqing Zhao, et al.
Published: (2007-01-01) -
Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer
by: Kazuya Maeda, et al.
Published: (2020-04-01) -
Prognostic Significance of the Tumor-Stroma Ratio in Epithelial Ovarian Cancer
by: Ying Chen, et al.
Published: (2015-01-01) -
AEG-1 as a predictor of sensitivity to neoadjuvant chemotherapy in advanced epithelial ovarian cancer
by: Wang Y, et al.
Published: (2016-04-01)